Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics
Introduction
Severe hypoglycaemia (SH), requiring external assistance for recovery, is a common, feared and challenging complication of type 1 diabetes. It can result in collapse without warning, seizures, coma or death. Recurrent SH poses a significant challenge in terms of risk to personal safety, loss of personal control and independence, quality of life and mood changes [1]. Over time the awareness of hypoglycaemic symptoms diminishes which increases the annual risk of SH sixfold [2]. In unselected populations, between 30% and 40% of adults with type 1 diabetes have at least one SH event per year [2], [3], [4] depending on the definition and method of assessment of SH, and duration of diabetes. In a large Australian survey conducted in 2011, 20% of adults with type 1 diabetes reported having had at least one SH event in the past six months [5]. Adults who have diabetes for >15 years experienced higher rates of SH than those with diabetes for <5 years (22% versus 46%) [6].
Over the past decade, a significant decrease has been observed in the rates of SH in an Australian cohort of children and adolescents with type 1 diabetes [7], which may relate to the greater use of continuous subcutaneous insulin infusion (CSII) and modern insulins. Such data are unavailable for Australian adults. Internationally, studies conducted during the past decade have shown no change in the frequency of hypoglycaemia in adults with diabetes [2]. Today, as it was a decade ago, SH and fear thereof, remains the greatest barrier to achieving optimum glycaemic control [8].
The unpleasant symptoms and consequences of hypoglycaemic episodes can lead to fear of hypoglycaemia and impaired quality of life, for the person with diabetes [9], [10] as well as for their relatives [11]. A consistent association has been reported between fear of hypoglycaemia and the frequency of (severe] hypoglycaemic events [10], [12]. Experiencing one SH event has been shown to have an immediate negative impact on mood (increased fear of hypoglycaemia) and behaviour (reduction of insulin dose), which complicates improvement of clinical outcomes [10], [13]. Despite these findings, fear of hypoglycaemia frequently remains unrecognised [2].
The frequency of SH and impaired awareness of hypoglycaemia (IAH) in unselected clinic samples of adults with type 1 diabetes in Australia is unknown, nor has the psychological impact of SH been studied. Therefore, our aim was to examine self-reported prevalence of hypoglycaemia in a population of Australian adults with type 1 diabetes attending one of three specialist diabetes clinics; and to explore its associations with IAH, clinical, psychological and socio-demographic factors [14].
Section snippets
Setting and participants
Participants were recruited from three metropolitan specialist clinics: Royal Melbourne Hospital (site 1), St Vincent's Public Hospital (site 2), Baker IDI Heart and Diabetes Institute (site 3). In general, adults with type 1 diabetes attend these clinics on a quarterly basis, so data were collected over 8 to 12 weeks to capture people attending for routine appointments and to minimise risk of duplication. Data collections took place between October and December 2011 (site 1), and between
Participants
Of the 502 eligible adults invited to take part, 444 (88.4%) gave consent and completed the survey. An additional 22 questionnaires were discarded due to missing data, providing an overall response rate of 422 (84.1%). The majority (91.0%) completed the questionnaire in the waiting room, with 9.0% completing it at home (e.g. experiencing hypoglycaemia in the clinic). Socio-demographic and clinical characteristics of the total sample and by SH are summarised in Table 1. HbA1c had been assessed
Discussion
Our findings demonstrate that completion of a detailed hypoglycaemia and well-being assessment tool was both feasible and acceptable to patients during a routine clinic visit, resulting in a response rate of 88.4%. In three unselected clinic populations, with a combined sample of over 400 adults with type 1 diabetes, one in five participants reported at least one SH episode in the past six months, an average of one SH event per year per person. This annual rate falls within the range of 1.0 to
Conclusion
This study has shown that it is feasible and acceptable to invite clinic attendees to complete a questionnaire about hypoglycaemic events, IAH and psychological well-being. For routine clinical practice, we recommend a brief, standardised IAH and SH assessment (such as the items used here), which will take no more than 5 minutes to complete.
One in five Australian adults with type 1 diabetes experienced a SH event in the past six months, which was associated with impaired hypoglycaemic awareness,
Conflict of interest statement
The authors declare they have no conflict of interest.
Acknowledgements
We thank Elizabeth Maclean for data collection at Baker IDI, Daniel Calandro for data collection assistance at SVH, Lucy Morrish for data collection assistance at RMH, and Laura Smith and Anna Scovelle for biomedical data input and quality control of the survey data. We thank the participants for their contribution to this project. We also thank Diabetes Australia–Vic and Deakin University for their financial support.
References (32)
- et al.
Hypoglycaemia: an overview
Primary Care Diabetes
(2009) - et al.
Insulin analogues and severe hypoglycaemia in type 1 diabetes
Diabetes Res Clin Pract
(2012 4) - et al.
A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education
Patient Educ Couns
(2007) - et al.
Sudden death in type 1 diabetes: the mystery of the ‘dead in bed’ syndrome
Int J Cardiol
(2010) - et al.
Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way?
Diabetes Metab
(2013) How hypoglycaemia can affect the life of a person with diabetes
Diabetes/Metab Rev
(2008)- et al.
Hypoglycaemia: current management and controversies
Postgrad Med J
(2011) - et al.
Diabetes MILES—Australia 2011 survey report
(2011) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
Diabetologia
(2007)- et al.
Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000–2009
Diabetes Care
(2011)
The limiting factor in the glycaemic management of type I and type II diabetes
Diabetologia
Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes
Diabetes Care
The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes
Diabetes Care
Fear of hypoglycaemia in adults with type 1 diabetes
Diabetic Med
Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management
Can J Diabetes
Prevalence of self-reported severe hypoglycaemia in adults with type 1 diabetes attending tertiary diabetes clinics in Melbourne
Cited by (65)
Diabetes and Mental Health
2023, Canadian Journal of DiabetesThe impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: A systematic review
2021, Diabetes Research and Clinical PracticeCitation Excerpt :There is insufficient evidence to draw conclusions regarding the impact of hypoglycaemia on generic domains of QoL. Seventeen of the 30 studies (57%) examined associations between hypoglycaemia and FoH, with 15 studies investigating severe hypoglycaemia and 7 studies investigating self-treated hypoglycaemia [3,24,25,27–29,33,35,38,39,41,43,44,46–49]. Four studies found a significant positive correlation between FoH and self-treated hypoglycaemia [24,25,38,44].
The diagnosis and management of diabetes in Australia: Does the “Rule of Halves” apply?
2020, Diabetes Research and Clinical PracticeHypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
2019, The Lancet Diabetes and Endocrinology